AI assistant
Sending…
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — Director's Dealing 2013
Nov 25, 2013
30798_dirs_2013-11-25_39958eb7-0a1b-4a75-a888-c45a04a12381.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL)
CIK: 0001100682
Period of Report: 2013-11-22
Reporting Person: FOSTER JAMES C (Director, Chairman, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-22 | Common Stock | M | 84550 | $46.60 | Acquired | 448930 | Direct |
| 2013-11-22 | Common Stock | S | 84550 | $52.00 | Disposed | 364380 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-22 | Stock Options (Right to Buy) | $46.60 | M | 84550 | Disposed | 2014-02-23 | Common Stock (84550) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 340 | Indirect |
| Common Stock | 10000 | Indirect |
Footnotes
F1: This sale occured pursuant to a 10b5-1 Trading Plan.
More from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Regulatory Filings
2026
Feb 25
Regulatory Filings
2026
Feb 18
Annual Report
2026
Feb 18
Regulatory Filings
2026
Feb 18
Major Shareholding Notification
2026
Feb 10